All In Biotech

Drug Trial Radar · NCT05855967

A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India

A 24-Week Multicenter, Open-label, Single-arm, Phase 4 Study to Evaluate the Safety of Ixekizumab in Patients With Moderate-to-Severe Plaque Psoriasis or Active Psoriatic Arthritis in India

Last checked: Nov 20, 2026Latest source record: Aug 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

250

Actual

Start

Jun 27, 2023

Primary completion

Aug 8, 2024

Study completion Sep 23, 2024

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
May 12, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to investigate the safety and tolerability of ixekizumab in participants in India with moderate-to-severe plaque psoriasis (PsO) or active psoriatic arthritis (PsA)

Conditions

  • Plaque Psoriasis
  • Psoriatic Arthritis

Interventions

  • IxekizumabDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Reporting Serious Adverse Events (SAEs), and Treatment Emergent Adverse Events (TEAEs) and AEs of Special Interests (AESIs) From Week 0 to Week 24Time frame: Week 0 to Week 24

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • King George Hospital

    Vizag, Andhra Pradesh, India

  • All India Institute of Medical Sciences

    Raipur, Chhattisgarh, India

  • V.S. General Hospital

    Ahmedabad, Gujarat, India

  • Amber Clinic

    Ahmedabad, Gujarat, India

  • B. J. Medical College & Civil Hospital

    Ahmedabad, Gujarat, India

  • GMERS Medical College & Hospital

    Ahmedabad, Gujarat, India

  • Tristar Hospital

    Surat, Gujarat, India

  • Father Muller Medical College Hospital

    Mangalore, Karnataka, India

  • Dr. D. Y. Patil Medical College & Hospital

    Navi Mumbai, Maharashtra, India

  • Grant Medical Foundation - Ruby Hall Clinic

    Pune, Maharashtra, India

  • Oyster & Pearl Hospitals (Phadnis Clinic Pvt. Ltd.)

    Pune, Maharashtra, India

  • Postgraduate Institute of Medical Education & Research

    Chandigarh, Punjab, India

  • Wizderm Specialty Skin And Hair Clinic

    Kolkata, West Bengal, India

  • Medical College & Hospital

    Kolkata, West Bengal, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.